Nitric oxide in liver inflammation and regeneration

Metabolic Brain Disease

Volumn 17, Issue 4, 2002, Pages 325-334

  Martin Sanz, Paloma ^a   Hortelano, Sonsoles ^a   Callejas, Nuria A ^a   Goren, Nora ^a   Casado, Marta ^a   Zeini, Miriam ^a   Boscá, Lisardo ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Apoptosis; Liver inflammation; Liver regeneration; Nitric oxide; Transcription factors

Indexed keywords

CYTOKINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; BACTERIAL CELL WALL; CELL CYCLE; CONFERENCE PAPER; GENE EXPRESSION REGULATION; HEPATITIS; INFLAMMATION; LIVER CELL; LIVER FUNCTION; LIVER REGENERATION; LIVER SIZE; MEDIATOR RELEASE; NONHUMAN; PARTIAL HEPATECTOMY; PROTEIN EXPRESSION; SYNTHESIS;

ANIMALS; HEPATECTOMY; HEPATITIS; LIVER REGENERATION; NITRIC OXIDE;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0036984364     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021909902310     Document Type: Conference Paper

References (67)

1. Baeuerle, P.A. (1998). IκB-NF-κB structures: At the interface of inflammation control. Cell 95:729-731.
2. Baeuerle, P.A., and Baichwal, V.R. (1997). NF-kB as a frequent target for immunosuppressive and antiinflammatory molecules. Adv. Immunol. 65:111-137.
3. Bellas, R.E., FitzGerald, M.J., Fausto, N., and Sonenshein, G.E. (1997). Inhibition of NF-κB activity induces apoptosis in murine hepatocytes. Am. J. Pathol. 151:891-896.
4. Camargo, C.A.J., Madden, J.F., Gao, W., Selvan, R.S., and Clavien, P.A. (1997). Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26:1513-1520.
5. Campbell, J.S., Prichard, L., Schaper, F., Schmitz, J., Stephenson-Famy, A., Rosenfeld, M.E., et al. (2001). Expression of suppressors of cytokine signaling during liver regeneration. J. Clin. Invest. 107:1285-1292.
6. Casado, M., Callejas, N.A., Rodrigo, J., Zhao, X., Dey, S.K., Bosca, L., et al. (2001). Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy. FASEB J. 15:2016-2018.
7. Clavien, P.A. (1997). IL-6, a key cytokine in liver regeneration. Hepatology 25:1294-1296.
8. Clemens, M.G. (1999). Nitric oxide in liver injury. Hepatology 30:1-5.
9. Cressman, D.E., Greenbaum, L.E., DeAngelis, R.A., Ciliberto, G., Furth, E.E., Poli, V., et al. (1996). Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274:1379-1383.
10. Curran, R.D., Billiar, T.R., Stuehr, D.J., Hofmann, K., and Simmons, R.L. (1989). Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J. Exp. Med. 170:1769-1774.
11. DeAngelis, R.A., Kovalovich, K., Cressman, D.E., and Taub, R. (2001). Normal liver regeneration in p50/nuclear factor κB1 knockout mice. Hepatology 33:915-924.
12. Debonera, F., Aldeguer, X., Shen, X., Gelman, A.E., Gao, F., Que, X., et al. (2001). Activation of interleukin-6/STAT3 and liver regeneration following transplantation. J. Surg. Res. 96:289-295.
13. DeWitt, D.L. (1991). Prostaglandin endoperoxide synthase: Regulation of enzyme expression. Biochim. Biophys. Acta 1083:121-134.
14. Diaz-Guerra, M.J., Velasco, M., Martin-Sanz, P., and Bosca, L. (1996). Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes. Requirement of NF-κB activation after stimulation with bacterial cell wall products and phorbol esters. J. Biol. Chem. 271:30114-30120.
15. Diaz-Guerra, M.J., Velasco, M., Martin-Sanz, P., and Bosca, L. (1997). Nuclear factor κB is required for the transcriptional control of type II NO synthase in regenerating liver. Biochem. J. 326:791-797.
16. Diehl, A.M., and Rai, R.M. (1996). Liver regeneration 3: Regulation of signal transduction during liver regeneration. FASEB J. 10:215-227.
17. Diez-Fernandez, C., Sanz, N., Bosca, L., Hortelano, S., and Cascales, M. (1997). Involvement of nitric oxide synthesis in hepatic perturbations induced in rats by a necrogenic dose of thioacetamide. Br. J. Pharmacol. 121:820-826.
18. Fausto, N. (1999). Lessons from genetically engineered animal models. V. Knocking out genes to study liver regeneration: Present and future. Am. J. Physiol. 277:G917-G921.
19. Fausto, N. (2000). Liver regeneration. J. Hepatol. 32:19-31.
20. Fausto, N., Laird, A.D., and Webber, E.M. (1995). Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J. 9:1527-1536.
21. Fry, D.E. (2000). Sepsis syndrome. Am. Surg. 66:126-132.
22. Galea, E., and Feinstein, D.L. (1999). Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J. 13:2125-2137.
23. Gallucci, R.M., Simeonova, P.P., Toriumi, W., and Luster, M.I. (2000). TNF-α regulates transforming growth factor-alpha expression in regenerating murine liver and isolated hepatocytes. J. Immunol. 164:872-878.
24. Glockzin, S., von Knethen, A., Scheffner, M., and Brune, B. (1999). Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J. Biol. Chem. 274:19581-19586.
25. Goss, J.A., Mangino, M.J., Callery, M.P., and Flye, M.W. (1993). Prostaglandin E2 downregulates Kupffer cell production of IL-1 and IL-6 during hepatic regeneration. Am. J. Physiol. 264:G601-G608.
26. Greenbaum, L.E., Li, W., Cressman, D.E., Peng, Y., Ciliberto, G., Poli, V., et al. (1998). CCAAT enhancer-binding protein b is required for normal hepatocyte proliferation in mice after partial hepatectomy. J. Clin. Invest. 102:996-1007.
27. Guidotti, L.G., McClary, H., Loudis, J.M., and Chisari, F.V. (2000). Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J. Exp. Med. 191:1247-1252.
28. Hickey, M.J., Sharkey, K.A., Sihota, E.G., Reinhardt, P.H., Macmicking, J.D., Nathan, C., et al. (1997). Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 11:955-964.
29. Hierholzer, C., Harbrecht, B., Menezes, J.M., Kane, J., MacMicking, J., Nathan, C.F., et al. (1998). Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J. Exp. Med. 187:917-928.
30. Hollenberg, S.M., Easington, C.R., Osman, J., Broussard, M., and Parrillo, J.E. (1999). Effects of nitric oxide synthase inhibition on microvascular reactivity in septic mice. Shock 12:262-267.
31. Hollenberg, S.M., Broussard, M., Osman, J., and Parrillo, J.E. (2000). Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ. Res. 86:774-778.
32. Hortelano, S., Dewez, B., Genaro, A.M., Diaz-Guerra, M.J., and Bosca, L. (1995). Nitric oxide is released in regenerating liver after partial hepatectomy. Hepatology 21:776-786.
33. Huang, P.L., and Fishman, M.C. (1996). Genetic analysis of nitric oxide synthase isoforms: Targeted mutation in mice. J. Mol. Med. 74:415-421.
34. Kaplowitz, N. (2000). Mechanisms of liver cell injury. J. Hepatol. 32(Suppl. 1):39-47.
35. Kim, Y.M., Talanian, R.V., and Billiar, T.R. (1997). Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J. Biol. Chem. 272:31138-31148.
36. Knight, B., Yeoh, G.C., Husk, K.L., Ly, T., Abraham, L.J., Yu, C., et al. (2000). Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J. Exp. Med. 192:1809-1818.
37. Kumins, N.H., Hunt, J., Gamelli, R.L., and Filkins, J.P. (1997). Molsidomine increases endotoxic survival and decreases cytokine production. Shock 7:200-205.
38. Lavon, I., Goldberg, I., Amit, S., Landsman, L., Jung, S., Tsuberi, B.Z., et al. (2000). High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation. Nat. Med. 6:573-577.
39. Lee, L.A. (2001). Advances in hepatocyte transplantation: A myth becomes reality. J. Clin. Invest. 108:367-369.
40. Li, J., and Billiar, T.R. (1999a). Nitric oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am. J. Physiol. 276:G1069-G1073.
41. Li, J., and Billiar, T.R. (1999b). The anti-apoptotic actions of nitric oxide in hepatocytes. Cell Death Differ. 6:952-955.
42. MacMicking, J., Xie, Q.W., and Nathan, C. (1997). Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.
43. Martin-Sanz, P., Callejas, N.A., Casado, M., Diaz-Guerra, M.J., and Bosca, L. (1998). Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines. Br. J. Pharmacol. 125:1313-1319.
44. Michalopoulos, G.K., and DeFrances, M.C. (1997). Liver regeneration. Science 276:60-66.
45. Mojena, M., Hortelano, S., Castrillo, A., Diaz-Guerra, M.J., Garcia-Barchino, M.J., Saez, G.T., et al. (2001). Protection by nitric oxide against liver inflammatory injury in animals carrying a nitric oxide synthase-2 transgene. FASEB J. 15:583-585.
46. Morikawa, A., Kato, Y., Sugiyama, T., Koide, N., Chakravortty, D., Yoshida, T., et al. (1999). Role of nitric oxide in lipopolysaccharide-induced hepatic injury in D-galactosamine-sensitized mice as an experimental endotoxic shock model. Infect. Immun. 67:1018-1024.
47. Nussler, A.K., Beger, H.G., Liu, Z.Z., and Billiar, T.R. (1995). Nitric oxide, hepatocytes and inflammation. Res. Immunol. 146:671-677.
48. Obolenskaya, M., Schulze-Specking, A., Plaumann, B., Frenzer, K., Freudenberg, N., and Decker, K. (1994a). Nitric oxide production by cells isolated from regenerating rat liver. Biochem. Biophys. Res. Commun. 204:1305-1311.
49. Obolenskaya, M.Y., Vanin, A.F., Mordvintcev, P.I., Mulsch, A., and Decker, K. (1994b). Epr evidence of nitric oxide production by the regenerating rat liver. Biochem. Biophys. Res. Commun. 202:571-576.
50. Pastor, C.M., Losser, M.R., and Payen, D. (1995). Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits. Hepatology 22:1547-1553.
51. Rai, R.M., Lee, F.Y., Rosen, A., Yang, S.Q., Lin, H.Z., Koteish, A., et al. (1998). Impaired liver regeneration in inducible nitric oxide synthase deficient mice. Proc. Natl. Acad. Sci. U.S.A. 95:13829-13834.
52. Rosenfeld, M.E., Prichard, L., Shiojiri, N., and Fausto, N. (2000). Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am. J. Pathol. 156:997-1007.
53. Sakamoto, T., Liu, Z., Murase, N., Ezure, T., Yokomuro, S., Poli, V., et al. (1999). Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 29:403-411.
54. Schoen, J.M., Wang, H.H., Minuk, G.Y., and Lautt, W.W. (2001). Shear stress-induced nitric oxide release triggers the liver regeneration cascade. Nitric Oxide 5:453-464.
55. Scotte, M., Masson, S., Lyoumi, S., Hiron, M., Teniere, P., Lebreton, J. P., et al. (1997). Cytokine gene expression in liver following minor or major hepatectomy in rat. Cytokine 9:859-867.
56. Streetz, K.L., Wustefeld, T., Klein, C., Manns, M.P., and Trautwein, C. (2001). Mediators of inflammation and acute phase response in the liver. Cell. Mol. Biol. 47:661-673.
57. Szabo, C., and Billiar, T.R. (1999). Novel roles of nitric oxide in hemorrhagic shock. Shock 12:1-9.
58. Taub, R. (1998). Blocking NF-κB in the liver: The good and bad news. Hepatology 27:1445-1446.
59. Taylor, B.S., and Geller, D.A. (2000). Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 13:413-424.
60. Taylor, B.S., Shao, L., Gambotto, A., Ganster, R.W., and Geller, D.A. (1999). Inhibition of cytokine-induced nitric oxide synthase expression by gene transfer of adenoviral IκBα. Surgery 126:142-147.
61. Titheradge, M.A. (1999). Nitric oxide in septic shock. Biochim. Biophys. Acta 1411:437-455.
62. Velasco, M., Diaz-Guerra, M.J., Martin-Sanz, P., Alvarez, A., and Bosca, L. (1997). Rapid Up-regulation of IκBb and abrogation of NF-κB activity in peritoneal macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 272:23025-23030.
63. Vos, T.A., Gouw, A.S., Klok, P.A., Havinga, R., van Goor, H., Huitema, S., et al. (1997). Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats. Gastroenterology 113:1323-1333.
64. Webber, E.M., Bruix, J., Pierce, R.H., and Fausto, N. (1998). Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 28:1226-1234.
65. Xie, Q.W., Whisnant, R., and Nathan, C. (1993). Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by IFNγ and bacterial lipopolysaccharide. J. Exp. Med. 177:1779-1784.
66. Yamada, Y., Webber, E.M., Kirillova, I., Peschon, J.J., and Fausto, N. (1998). Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: Requirement for type 1 but not type 2 receptor. Hepatology 28:959-970.
67. Yamashita, T., Kawashima, S., Ohashi, Y., Ozaki, M., Ueyama, T., Ishida, T., et al. (2000). Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. Circulation 101:931-937.